Thank you for joining us @ booth 4088 and at the bar during the social event. If you haven't stopped by yet, today is your last chance to meet our crew #SNMMI2023
Meet us at #EMIM2023, March 14-17, and discover our preclinical imaging solutions. In addition, join the #MILabs Lunch Symposium on March 15, starting at 12.15 pm, and learn about exciting features and applications of MILabs imaging systems.
#molecularimaging#preclinicalimaging
The use of modified bismuth-based mesoporous-silica-coated nanoparticles in #CT#cancerimaging and image-guided synergistic photothermal chemotherapy was investigated. Imaging platform: #MILabs U-CT system.
Publication in Advanced Optical Materials: onlinelibrary.wiley.com/doi/…
New FAP-targeted radioligand therapy (RLT) comprised of a FAP6 ligand conjugated to DOTA and an albumin-binder developed. Its performance was evaluated #invivo in four different murine #tumor models using an #MILabs#VECTorCT imaging instrument.
jnm.snmjournals.org/.../2022…